Neuroone Medical Technologies (NMTC) Total Non-Current Liabilities (2016 - 2026)

Neuroone Medical Technologies has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $1.8 million for Q1 2026.

• Quarterly Total Non-Current Liabilities fell 9.57% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 9.57% YoY) and the FY2025 annual result came in at $2.4 million, up 1.6% from the prior year.
• Total Non-Current Liabilities climbed to $1.8 million in Q1 2026, from $1.4 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $2.4 million in Q3 2025 and bottomed at $1.4 million in Q4 2025.
• The 3-year median for Total Non-Current Liabilities is $1.8 million (2024), against an average of $1.9 million.
• The widest YoY moves for Total Non-Current Liabilities: up 1.6% in 2025, down 24.3% in 2025.
• Neuroone Medical Technologies' Total Non-Current Liabilities stood at $1.8 million in 2024, then slipped by 24.3% to $1.4 million in 2025, then soared by 30.17% to $1.8 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.8 million, $1.4 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.